Axon sells $1.15 billion of 0% convertible senior notes due 2031
Axon issued and sold $1,150.0 million of 0% convertible senior notes due September 15, 2031, on September 18, 2026, including $150.0 million from the full exercise of the underwriters' over-allotment option. The initial conversion price is about $652.06 per share, compared with a last reported sale price of $442.08 on September 15, 2026, so conversion could dilute existing shareholders. The company said capped call transactions are expected to reduce that potential dilution, subject to a cap price of $1,049.94.
Key points
- Principal of $1,150.0 million issued September 18, 2026, including $150.0 million from full exercise of the over-allotment option
- Notes bear no regular interest and mature September 15, 2031; initial conversion rate of 1.5336 shares per $1,000 principal
- Expected net proceeds of about $1,134.3 million if the over-allotment option is exercised in full, with about $114.9 million used for capped call transactions
- Holders may require repurchase at par on or around March 20, 2031, and the company may redeem for cash on or after September 20, 2029, under specified conditions
The filing
Written by AI on Nov 8, 2026, 1:10 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 21, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.